[Schizophrenia: adverse effects of atypical neuroleptics].
Bettina Polk
Bericht
B
Redaktion Medizinische Monatsschrift für Pharmazeuten, Birkenwaldstr. 44, 70191 Stuttgart. bpolk@wissenschaftliche-verlagsgesellschaft.de
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D008133:Long QT Syndrome / Q000139:chemically induced; D011388:Prolactin / Q000097:blood; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy*; D015430:Weight Gain / Q000187:drug effects
D014150:Antipsychotic Agents; D011388:Prolactin